Synchrony Financial, together with its subsidiaries, operates as a consumer financial services company in the United States. It provides credit products, such as credit cards, commercial credit products, and consumer installment loans. The company also offers private label credit cards, dual cards, co-brand and general purpose credit cards, short- and long-term installment loans, and consumer banking products; and deposit products, including certificates of deposit, individual retirement accounts, money market accounts, and savings accounts to retail and commercial customers, as well as accepts deposits through third-party securities brokerage firms. In addition, it provides debt cancellation products to its credit card customers through online, mobile, and direct mail; healthcare payments and financing solutions under the CareCredit, Pets Best, and Walgreens brands; payments and financing solutions in the apparel, specialty retail, outdoor, music, and luxury industries; and point-of-sale consumer financing for audiology products and dental services. The company offers its credit products through programs established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers; and deposit products through various channels, such as digital and print. It serves digital, health and wellness, retail, home, auto, powersports, jewelry, pets, and other industries. Synchrony Financial was founded in 1932 and is headquartered in Stamford, Connecticut.
Synchrony Financial Stock Down 1.1 %
Synchrony Financial stock opened at $35.75 on Tuesday. Synchrony Financial has a twelve month low of $27.22 and a twelve month high of $52.49. The stock has a 50 day moving average of $31.55 and a two-hundred day moving average of $35.79. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $17.22 billion, a price-to-earnings ratio of 5.22, a PEG ratio of 0.27 and a beta of 1.57.
Synchrony Financial (NYSE:SYF - Get Rating) last posted its quarterly earnings results on Monday, July 18th. The financial services provider reported $1.60 EPS for the quarter, beating the consensus estimate of $1.47 by $0.13. Synchrony Financial had a return on equity of 27.06% and a net margin of 22.76%. During the same period in the previous year, the company posted $2.12 earnings per share. As a group, research analysts expect that Synchrony Financial will post 5.8 earnings per share for the current year.
Synchrony Financial Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, August 11th. Stockholders of record on Monday, August 1st were issued a $0.23 dividend. This is a boost from Synchrony Financial's previous quarterly dividend of $0.22. This represents a $0.92 annualized dividend and a dividend yield of 2.57%. The ex-dividend date of this dividend was Friday, July 29th. Synchrony Financial's dividend payout ratio (DPR) is currently 13.43%.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on SYF shares. Piper Sandler set a $41.00 price objective on Synchrony Financial in a report on Tuesday, July 19th. Wells Fargo & Company cut Synchrony Financial from an "overweight" rating to an "equal weight" rating and decreased their target price for the company from $45.00 to $32.00 in a research report on Wednesday, July 13th. Morgan Stanley decreased their target price on Synchrony Financial from $40.00 to $31.00 and set an "equal weight" rating for the company in a research report on Tuesday, July 12th. The Goldman Sachs Group upped their target price on Synchrony Financial from $40.00 to $45.00 and gave the company a "buy" rating in a research report on Tuesday, April 19th. Finally, StockNews.com raised Synchrony Financial from a "hold" rating to a "buy" rating in a research report on Monday, July 25th. One analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $45.76.